Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Kidney Stone Institute (IKSI) is a prominent non-profit organization dedicated to the advancement of research, treatment, and prevention of kidney stone disease. Based in Indianapolis and closely affiliated with Indiana University Health and the IU School of Medicine, the institute is recognized globally for its clinical excellence and pioneering work in urology. IKSI focuses on refining minimally invasive surgical techniques, including extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL). Beyond surgical intervention, the institute conducts extensive research into the metabolic causes of stone formation to develop better preventative strategies. Its collaborative environment brings together leading urologists and researchers to improve patient outcomes and establish international standards of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Kidney Stone Institute.